Root Financial Partners’s Astrana Health ASTH Stock Holding History

Root Financial Partners’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$57	–	2538
2025 Q3	$57	Buy	+2	New	+$54	﹤0.01%	2265

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Root Financial Partners's ASTH Position: Q4 2025 in Review

Root Financial Partners sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 2 shares — an estimated $57 sold.

Root Financial Partners first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $57 in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

Root Financial Partners reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
Root Financial Partners sold 2 Astrana Health shares in Q4 2025, an estimated $57.
Root Financial Partners first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
Root Financial Partners's Astrana Health position peaked at $57 in Q3 2025.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Root Financial Partners's 13F filing for Q4 2025, filed 10 Feb 2026.